T of B-cell-specific antigens and low-density membrane Ig, usually of p or p and 6 H chain isotype in combination with K or X L chains.' In addition, more than 90% of CLL cases express the CD5 antigen, aglycoprotein normally present on T cells and a subpopulation of B lymphocytes.24 To elucidate the ontogenic origin of CLL and evaluate tumor progression in vivo, several groups of investigators have analyzed the molecular structure of the V genes expressed in these
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The collective data show that all six V, gene families are used in CLL and that the largest V,3 gene family is used most frequently, roughly in proportion to its relative size in the genome. 16 In contrast, rearrangements of members of the V,4, vH5, and V,6 gene families occur more frequently than expected from their respective sizes in the g e n~m e .~,~~' '~'~ Furthermore, 5 1P1 and Humkv325, members of the multigene V, 1 and V,III families, respectively, have been found with striking frequency in CLL, whereas no such overrepresentation is apparent fok individual members of the V,3 gene family.'0*'2,'6 The majority of V, and V, genes expressed in CD5+ IgM-bearing CLL cases are in germline configuration and display little intraclonal diversification. An exception seems to be CLL cases that express V,5 genes that reportedly contain many somatic m~t a t i o n s . '~~' '~'~ A small proportion of CLL cases is characterized by the expression of membrane Ig of y or a isotype. At present it is unknown whether the V regions of CLL tumors bearing these isotypes resemble those expressed in IgM CLL or, alternatively, display characteristics associated with a different B-cell subpopulation or stage of B-cell differentiation. To address this issue we have analyzed the nucleotide sequences of the V, and V, genes expressed in two cases of CD5+ IgG CLL. One CLL case expressed a somatically mutated variant of the Humkv325 gene that is often found in unmutated configuration in IgM-bearing CLL. The other CLL case expressed the developmentally restricted VH3.38P1 gene in or near germline configuration. The results support the hypothesis that CLL is a heterogeneous group of tumors representing various stages of the B-cell differentiation pathway.
MATERIALS AND METHODS

Patient population.
Heparinized blood samples were collected from two patients with documented CLL. Mononuclear cells (MNC) were prepared by Ficoll-hypaque (ICN Flow, Costa Mesa, CA) density gradient centrifugation as described." MNC were stained with fluorescein isothiocyanate-conjugated MoAbs to human CD5, CD19 (Becton Dickinson, Mountain View, CA) IgM, IgD, IgG, IgA, K , and X light chains (Southern Biotechnology Associates, Birmingham, AL) and analyzed on a FACScan (Becton Dickinson). The two CLL cases P87 and PI03 described in this study expressed CD5 and surface lgGX and IgGK isotype, respectively (Table 1 and Fig 1) . Expression of membrane IgM or IgD was not detectable. Tumor loads were 139 X lo6 and 46 X lo6 MNC/ mL of peripheral blood, respectively.
Preparation ofRNA andfirst-strand cDNA synthesis. RNA was extracted from lo8 cells using the guanidium isothiocyanate method. First-strand cDNA was prepared from 10 pg of total RNA according to standard protocol^.^^ Briefly, an oligo-(dT) primer was hybridized to 10 pg RNA and extended with 10 U of avian myeloblastosis virus (AMV) reverse transcriptase.16 For each patient, two independent cDNA samples were prepared.
Cloning and sequencing of H and L chain V regions. For cloning of V, regions, cDNA samples were amplified in the polymerase chain reaction (PCR) using a 3' C,-specific primer and each of a set of 5' V, gene family-specific primers as previously described ( Table  2) .16 The 3'and 5' primers contained Xba I and EcoRI endonuclease restriction sites, respectively, to facilitate subcloning of the PCR products.
The V, region expressed by P103 was amplified with 5' V, gene family-specific and 3' C,-specific primers containing BamHI and Sal I endonuclease restriction sites respectively. The V, region ex- pressed by P87 was amplified using a 5' pan-V, primer in combination with a 3' C, primer with attached EcoRI and SUI I sites, respectively (Table 2) 
RESULTS
Cloning of CLL V regions.
We have cloned and sequenced the V, and V, regions expressed by two IgG-bearing CD5+ CLL cases, P87 and P103 (Table 1 and Fig 1) . Although the tumor load in both patients was very high log fluorescence Intensity (Table l) , the cDNA/PCR-based approach could potentially result in the amplification and cloning of V regions from contaminating B cells in the blood samples. To minimize this potential problem, we performed two cDNA/PCR reactions for each sample and obtained nucleotide sequences from independent cDNA clones.
In both CLL cases, a diagnostic DNA fragment ofapproximately 400 bp was obtained with the VH3-specific primer, whereas no amplification products were obtained with primers specific for the other V, gene families (results not shown). The amplified products were cloned into Bluescript and sequenced from two directions. In each patient, the V,DJ, joints of cDNA clones from independent cDNA/ PCR reactions were identical, rendering it highly likely that they were derived from the tumor.
The V, gene expressed in the malignant cells of patient P87 differed by three nucleotides from 38P1, a member of the VH3 gene family previously obtained from a fetal liver cDNA library (Fig 2) .20 One alteration in VH3.P87 is silent and localized in framework 2, whereas the other two are replacement mutations in complementarity determining region 2. The D gene segment is most homologous to the germline DN1 gene, whereas the JH gene is 100% identical to JH6 (Fig 2) .2',22 The V, gene expressed in the malignant cells of patient P 103 displayed the highest degree of homology (93.8%) to vH3.x15, a V,3 gene expressed by an Epstein-Barr virus-transformed B-cell line derived from a patient with X-linked agammaglobulinemia (release 34). 23 The J, gene differed by five nucleotides from JH4, whereas the D segment expressed in P103 displayed a moderate degree of homology with DNl (Fig 3) .21, 22 The V, gene expressed by P 103 differed by seven nucleotides from the germline Humkv325 gene segment (Fig 4,  Table 3 ). 24 The rearranged J, gene differed by four nucleotides from the previously reported germline J,1 gene seg- The V, -and V, family-specific primers were designed to anneal to the leader sequences of the V , and V, genes. The pan-V, primer is homologous to a common framework 1 sequence of all V, genes. Sequences not homologous to the specified gene segments are depicted in lower case letters. The endonuclease restriction sites are underlined. ment (Fig 3) . The X L chain used by P87 consisted of J and C regions belonging to subgroup 2, joined to a V, gene that displayed 82.4% homology to K6F5, a V, gene previously cloned from a follicular lymph~ma.*~,*~ The deduced amino EBELING, SCHUTTE, AND LOGTENBERG acid sequence shows that this V, gene belongs to the recently described subgroup IV of V, genes (Fig 5) .27
97.3%
For each CLL, we analyzed four V, and three V, cDNA clones obtained from two independently performed cDNA/ PCR reactions. All cDNA clones of V,3.P87, V,.P103 and V,.P87 were 100% identical, whereas only a single base difference could be detected in the three cDNA clones of VH3.P1O3 (Fig 2) . cells in the population, the somatic hypermutation mechanism is not activated during clonal outgrowth.8, '6 In that respect they may differ from rare CLL variants that do not express the CD5 m~l e c u l e . '~~~~ The V, genes expressed in the two IgG-bearing CLL cases analyzed in this study were identified as members of the large V,3 gene family, whereas the L chain V regions were encoded by members of the VJII and VJV gene families. Although the sample size is small, these data suggest that V gene expression patterns in IgG CLL resemble those observed in their IgM-bearing counterparts, ie, frequent use of members of the large vH3 gene family and overrepresentation of the single Humkv325 gene segment. Recently, a vH3 gene was also identified in an IgA-bearing CLL.28
The V, gene expressed in P87 differed by three nucleotides from 38P 1, a V,3 gene previously isolated from a second-trimester, fetal liver-derived cDNA library." Considering the source of this cDNA clone, 38P1 likely represents a germline gene, The three nucleotide differences between VH3.P87 and 38Pl gene could reflect a polymorphism, a closely related novel member of the VH3 gene family and/or somatic mutations. Based on the current data, we cannot discriminate between these alternatives.
The V, gene expressed in P103 was identified as a member of the VJII subgroup. The germline sequences of eight of nine members of this gene family have been characteri~ed.*~ Nucleotide sequence comparison showed seven differences between VK3.P1O3 and Humkv325, the most homologous germline VJII gene, whereas other germline V, genes display 95.5% or less homology. The Humkv325 gene is highly conserved in the human population, being 100% identical at the nucleotide level in at least nine different individuals a n a l y~e d . '~,~~,~~"~ Although we did not formally The nucleotide sequences of V,.P103 and V,.P87 differ extensively (93.8% and 82.4%, respectively) from the most homologous V, and V, germline genes in the database, precluding definitive conclusions on the origin of these expressed genes.
The analysis of seven cDNA clones from independent cDNA/PCR reactions of each patient showed a very high degree of homogeneity among sets of cDNAs representing each VK or V, gene, showing that the cells that belong to the malignant clone in IgG CLL display very little intraclonal diversification. In this respect, IgG CLL resembles IgM CLL, a single case of IgA CLL and small cell lymphocytic lymphoma, another CD5+ B-cell malignancy that shares many of the characteristics of IgM CLL. This clearly distinguishes these CD5+ B-cell tumors from follicular lymphomas that mutate extensively, and they have been postulated to represent a more mature B-cell phenotype.26333
Two scenarios may be envisaged to explain the origin of IgG CLL tumors. IgG CLL with mutated V regions may reflect a more mature stage of B-cell differentiation than their IgM-bearing counterparts. Indeed, during a primary immune response, isotype switching may occur in the absence or presence of somatic hypermutation, a pathway perhaps associated with both CD5-and CD5' B Alternatively, isotype switching may be an infrequent event associated with transformation, implying that the malignant cells are in fact representatives of fortuitously switched, IgM-bearing B cells. The VH3.P87 gene may be testament to such a scheme. The occurrence of somatic mutations in the V, region of P103 is not in contradiction with 
